Back
Exelixis Vs. BioCryst Pharmaceuticals Industry Stock Comparison
Buy
89
EXEL
Exelixis
Last Price:
34.31
Seasonality Move:
12.94%
Sell
29
BCRX
BioCryst Pharmaceuticals
Last Price:
7.15
Seasonality Move:
7.87%
Buy
89
Exelixis (EXEL)
is a Buy
Is Exelixis a Buy, Sell or Hold?
- The current Exelixis [EXEL] share price is $34.29. The Score for EXEL is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- EXEL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
29
BioCryst Pharmaceuticals (BCRX)
is a Sell
Is BioCryst Pharmaceuticals a Buy, Sell or Hold?
- The current BioCryst Pharmaceuticals [BCRX] share price is $7.35. The Score for BCRX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- BCRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EXEL Stock Price Chart
BCRX Stock Price Chart
What is BioCryst Pharmaceuticals's stock price today?
-
The BioCryst Pharmaceuticals share price today is $7.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCRX is experiencing slight selling pressure.
EXEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.74 | Buy |
| Relative Strength Index (14 RSI): | 82.52 | Buy |
| Chaikin Money Flow: | 490856 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.67 - 30.87) | Buy |
| Bollinger Bands (100): | (22.64 - 28.08) | Buy |
BCRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 42.54 | Sell |
| Chaikin Money Flow: | -1116227 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.31 - 8.05) | Sell |
| Bollinger Bands (100): | (6.79 - 8.11) | Sell |
EXEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.9 | Buy |
| 20-day SMA: | 28.76 | Buy |
| 50-day SMA: | 27.23 | Buy |
| 200-day SMA: | 23.75 | Buy |
| 8-day EMA: | 31.72 | Buy |
| 20-day EMA: | 29.6 | Buy |
| 50-day EMA: | 27.65 | Buy |
| 200-day EMA: | 24.45 | Buy |
BCRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.07 | Sell |
| 20-day SMA: | 7.73 | Sell |
| 50-day SMA: | 7.84 | Sell |
| 200-day SMA: | 6.42 | Buy |
| 8-day EMA: | 7.95 | Sell |
| 20-day EMA: | 7.85 | Sell |
| 50-day EMA: | 7.72 | Sell |
| 200-day EMA: | 7.02 | Buy |
Exelixis Earnings Growth & EXEL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and an increase next year of $0.01 per share.
BioCryst Pharmaceuticals Earnings Growth & BCRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.23 per share.
Exelixis Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioCryst Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||